Christine L. Mummery

SOST expression is restricted to the great arteries during embryonic and neonatal cardiovascular development.

Prospects for pluripotent stem cell-derived cardiomyocytes in cardiac cell therapy and as disease models.

Extracellular matrix formation after transplantation of human embryonic stem cell-derived cardiomyocytes.

Challenges in using stem cells for cardiac repair.

Cardiomyocyte differentiation of pluripotent stem cells and their use as cardiac disease models.

Pluripotent stem cell models of cardiac disease and their implication for drug discovery and development.

Shedding new light on the mechanism underlying stem cell therapy for the heart.

Human embryonic and fetal mesenchymal stem cells differentiate toward three different cardiac lineages in contrast to their adult counterparts.

New perspectives on regeneration of the heart.

Smooth muscle diversity from human pluripotent cells.

Cardiomyocytes derived from pluripotent stem cells recapitulate electrophysiological characteristics of an overlap syndrome of cardiac sodium channel disease.

Induced pluripotent stem cells: the new patient?

Model systems for cardiovascular regenerative biology.

Is heart regeneration on the right track?

Conversion of mature human β-cells into glucagon-producing α-cells.

Generation of induced pluripotent stem cells from human foetal fibroblasts using the Sleeping Beauty transposon gene delivery system.

Direct cardiomyocyte reprogramming: a new direction for cardiovascular regenerative medicine.

Functionality of endothelial cells and pericytes from human pluripotent stem cells demonstrated in cultured vascular plexus and zebrafish xenografts.

Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in long-QT syndrome.

PGC-1α and reactive oxygen species regulate human embryonic stem cell-derived cardiomyocyte function.

Strategies for rapidly mapping proviral integration sites and assessing cardiogenic potential of nascent human induced pluripotent stem cell clones.

Generation, expansion and functional analysis of endothelial cells and pericytes derived from human pluripotent stem cells.

SIRPA, VCAM1 and CD34 identify discrete lineages during early human cardiovascular development.

Serum supplemented culture medium masks hypertrophic phenotypes in human pluripotent stem cell derived cardiomyocytes.

Cell replacement therapies: is it time to reprogram?

Assessment of functional competence of endothelial cells from human pluripotent stem cells in zebrafish embryos.

A case for crowd sourcing in stem cell research.

Recessive cardiac phenotypes in induced pluripotent stem cell models of Jervell and Lange-Nielsen syndrome: disease mechanisms and pharmacological rescue.

Pluripotent stem cell derived cardiovascular progenitors--a developmental perspective.

Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes Under Defined Conditions.

Atrial-like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial-selective pharmacology.

Functional maturation of human pluripotent stem cell derived cardiomyocytes in vitro--correlation between contraction force and electrophysiology.

Lymphangiogenesis and angiogenesis during human fetal pancreas development.

Reply to Christ et al.: LQT1 and JLNS phenotypes in hiPSC-derived cardiomyocytes are due to KCNQ1 mutations.

What Endothelial Cells from Patient iPSCs Can Tell Us about Aortic Valve Disease.

The composition and differentiation potential of the duodenal intraepithelial innate lymphocyte compartment is altered in coeliac disease.

KeyGenes, a Tool to Probe Tissue Differentiation Using a Human Fetal Transcriptional Atlas.

Expansion and patterning of cardiovascular progenitors derived from human pluripotent stem cells.

Transcriptome of human foetal heart compared with cardiomyocytes from pluripotent stem cells.

Altered calcium handling and increased contraction force in human embryonic stem cell derived cardiomyocytes following short term dexamethasone exposure.

Contractile Defect Caused by Mutation in MYBPC3 Revealed under Conditions Optimized for Human PSC-Cardiomyocyte Function.

Induced Pluripotent Stem Cells to Model Human Fibrodysplasia Ossificans Progressiva.

Advantages of the avian model for human ovarian cancer.

Interaction Between ALK1 Signaling and Connexin40 in the Development of Arteriovenous Malformations.

The avian embryo to study development of the cardiac conduction system.

Complex Tissue and Disease Modeling using hiPSCs.

Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure.

Stem cells: The cancer's gone, but did chemotherapy damage your heart?

Concise Review: Measuring Physiological Responses of Human Pluripotent Stem Cell Derived Cardiomyocytes to Drugs and Disease.

Inherited heart disease - what can we expect from the second decade of human iPS cell research?

A new hERG allosteric modulator rescues genetic and drug-induced long-QT syndrome phenotypes in cardiomyocytes from isogenic pairs of patient induced pluripotent stem cells.

Integrating cardiomyocytes from human pluripotent stem cells in safety pharmacology: has the time come?

Readthrough-Promoting Drugs Gentamicin and PTC124 Fail to Rescue Nav1.5 Function of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Carrying Nonsense Mutations in the Sodium Channel Gene SCN5A.

Small molecule absorption by PDMS in the context of drug response bioassays.

TECRL, a new life-threatening inherited arrhythmia gene associated with overlapping clinical features of both LQTS and CPVT.

Interpretation of field potentials measured on a multi electrode array in pharmacological toxicity screening on primary and human pluripotent stem cell-derived cardiomyocytes.

Subtype-specific promoter-driven action potential imaging for precise disease modelling and drug testing in hiPSC-derived cardiomyocytes.

Three-dimensional cardiac microtissues composed of cardiomyocytes and endothelial cells co-differentiated from human pluripotent stem cells.

Differentiation-Defective Human Induced Pluripotent Stem Cells Reveal Strengths and Limitations of the Teratoma Assay and In Vitro Pluripotency Assays.

FANTOM5 CAGE profiles of human and mouse samples.

Human pluripotent stem cell models of cardiac disease: from mechanisms to therapies.

DNA methylation and transcriptional trajectories during human development and reprogramming of isogenic pluripotent stem cells.

Co-Differentiation of Human Pluripotent Stem Cells-Derived Cardiomyocytes and Endothelial Cells from Cardiac Mesoderm Provides a Three-Dimensional Model of Cardiac Microtissue.

Executive summary of the 12th HHT international scientific conference.

A COUP-TFII Human Embryonic Stem Cell Reporter Line to Identify and Select Atrial Cardiomyocytes.

Human Pluripotent Stem Cell Differentiation into Functional Epicardial Progenitor Cells.

MUSCLEMOTION: A Versatile Open Software Tool to Quantify Cardiomyocyte and Cardiac Muscle Contraction In Vitro and In Vivo.

Squaramide-Based Supramolecular Materials for Three-Dimensional Cell Culture of Human Induced Pluripotent Stem Cells and Their Derivatives.

NKX2-5 regulates human cardiomyogenesis via a HEY2 dependent transcriptional network.

Inflammatory Responses and Barrier Function of Endothelial Cells Derived from Human Induced Pluripotent Stem Cells.

Advanced in vitro models of vascular biology: Human induced pluripotent stem cells and organ-on-chip technology.

Quantification of Muscle Contraction In Vitro and In Vivo Using MUSCLEMOTION Software: From Stem Cell-Derived Cardiomyocytes to Zebrafish and Human Hearts.

Cytostretch, an Organ-on-Chip Platform.